Beta-carotene and other carotenoids: Promises, failures, and a new vision

Journal of Orthomolecular Medicine

Volumn 12, Issue 1, 1997, Pages 11-19

  Challem, Jack J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; CRYPTOXANTHIN; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN;

ARTICLE; HUMAN; ISOMER; LUNG CANCER; SMOKING;

EID: 0031011625     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Peto R, Doll R, Buckley JD, et al: Can dietary beta-carotene materially reduce human cancer rates? Nature, 1981;280:201-208.
2. De Luca LM and Ross SH: Beta-carotene increases lung cancer incidence in cigarette smokers. Nutr Rev, 1995;54:178-180.
3. Khachik F, Beecher GR, and Smith Jr JC: Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J of Cellular Biol, 1995;22 (Suppl):236-246.
4. Ziegler RG, Subar AF, Craft NE, et al.: Does beta-carotene explain why reduced cancer risk is associated with vegetable and fruit intake? Canc Res, 1992;52 (Suppl):2060-2066.
5. See Handelman GJ: Carotenoids as scavengers of active oxygen species. In eds. Cadenas E and Packer L, eds:Handbook of Antioxidants, Marcel Dekker, New York, 1996.
6. Di Mascio P, Murphy ME. Sies H: Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr, 1991;53:194S-200S.
7. Allard JP, Royall D, Kurian R, et al.: Effects of beta-carotene supplementation on lipid peroxidation in humans. Am J Clin Nutr, 1994;59:884-90.
8. Umegaki K, Ikegami S, Inoue K, et al.: Beta-carotene prevents x-ray induction of micronuclei in human lymphocytes. Am J Clin Nutr, 1994;59:409-412.
9. Gollnick HPM, Hopfenmüller, Hemmes C: Systemic beta carotene plus topical UV-sunscreen are an optimal protection against harmful effects of natural UV-sunlight: results of the Berline-Eilath study. Euro J Dermatol, 1996;6:200-205.
10. Moriguchi S, Okishima N, Sumida S, et al.: Beta-carotene supplementation enhances lymphocyte proliferation with mitogens in human peripheral blood lymphocytes. Nutr Reseach, 1996;16:211-218.
11. Garewal HS and Schantz S: Emerging role of beta-carotene and antioxidant nutrients in prevention of oral cancer. Archives Otolaryngology-Head and Neck Surgery, 1995; 121:141-144.
12. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med, 1994;330:1029-1035.
13. Albanes D, Heinonen OP, Taylor PR, et al.: Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention study: effects of baseline characteristics and study compliance. J Natl Canc Inst, 1996;88:1560-1570.
14. Bland J: The beta-carotene controversy in perspective. J of Appl Nutr, 1996;48:42-45.
15. Omenn GS, Goodman GE, Thornquist MD, et al.: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med, 1996;334:1150-1155.
16. Omenn GS, Goodman GE, Thornquist MD, et al.: Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Canc Inst, 1996;88:1550-1559.
17. Hennekens CH, Buring JE, Manson JE, et al.: Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Eng J Med, 1996;334:1145-1149.
18. Erdman JW Jr, Russell RM, Rock CL, et al.: Beta-carotene and the carotenoids: beyond the intervention trials. Nutr Rev, 1996;54:185-188.
19. Ben-Amotz A and Levy Y: Bioavailability of a natural isomer mixture compared with synthetic all-trans beta-carotene in human serum. Am J Clin Nutr, 1996;63:729-34.
20. Bland J, op. cit.
21. Ben-Amotz A and Levy Y, op. cit.
22. Challem JJ: Re: Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cane Inst, Feb 19, 1997;89: in press.
23. Ben-Amotz A and Levy Y, op. cit.
24. Ziegler RG, Colavito EA, Hartge P, et al.: Importance of alpha-carotene, beta-carotene, and other phytochemicals in the etiology of lung cancer. J Natl Canc Inst, 1996;88:612-615.
25. Le Marchand L, et al., Cancer Epidemiology, Biomarkers & Prevention, 1993; 2:183-7.
26. Greenberg ER, Baron JA, Karagas MR, et al.: Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA, 1996;275:699-703.
27. Rapola JM, Virtamo J, Haukka JK, et al.: Effect of vitamin E and beta carotene on the incidence of angina pectoris. JAMA, 1996;275:693-698.
28. Morris DL, Kritchevsky SB, and Davis CE: Serum carotenoids and coronary heart disease. JAMA, 1994;272:1439-1441.
29. Murakoshi M, Takayasu j, Kimura O, et al.: Inhibitory effects of alpha-carotene on proliferation of the human neuroblastoma cell line GOTA. J Nat Cane Inst 1989;81:1649-52.
30. Murakoshi M, Nishino H, Satomi Y, et al.: Potent preventive action of alpha-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting state of lung and skin carcinogenesis in mice are suppressed more effectively by alpha-carotene than by beta-carotene. Canc Res, 1992;52:6583-7.
31. Di Masco P, Kaiser S, Sies H: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys, 1989;274:532-538.
32. Miller NJ, Sampson J Candeias LP, et al.: Antioxidant activity of carotenes and xanthophylls. FEBS Letters, 1996;384:240-2.
33. Giovannucci E, Ascherio A, Rimm EB et al.: J Natl Canc Inst, 1995;87:1767-76.
34. Ibid.
35. Personal communication with E. Giovannucci, Harvard University, June 11, 1996.
36. Franceschi S, Bidoli E, La Vecchia C, et al.: Tomatoes and risk of digestive-tract cancers. Intl J Cancer, 1994;59:181-4
37. Kobayashi T, Iijima K, Mitamura T, et al.: Effects of lycopene, a carotenoid, on intrathymic T cell differentiation and peripheral CD4/CD8 ratio in a high mammary tumor strain of SHN retired mice. Anti-Cancer Drugs, 1996;7:195-8.
38. Seddon JM, Ajani UA, Sperduto RD, et al.: Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA, 1994;272:1413-20
39. Hammond Jr BR, Fuld K, and CurranCelentano J: Macular pigment in monozygotic twins. Invest Ophthal & Vis Sci, 1995;36:2431-41
40. Stampfer MJ and Willett WC: Correspondence. NEJM, 1996;335:669.
41. Personal communication, Jun 11, 1996.
42. Batieha AM, Armenian HK, Norkus EP, et al.: Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiology, Biomarkers & Prevention, 1993;2:335-9
43. Tsushima M, Maoka T, Katsuyama M, et al.: Inhibitory effect of natural carotenoids on Epstein-Barr virus activation activity of a tumor promoter in Raji cells. A screening study for anti-tumor promoters. Biological & Pharmaceutical Bulletin, 1995;18:227-33
44. Miller NJ, op. cit.
45. Chen H and Tappel AL: Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Rad Biol & Med, 1995;18:949-53.
46. Zhou JR. Gugger ET. Erdman JW Jr: The crystalline form of carotenes and the food matrix in carrot root decrease the relative bioavailabiliry of beta- and alpha-carotene in the ferret model. J Am Coll of Nutr, 1996;15:84-91.
47. Block G: Are clinical trials really the answer? Am J Clin Nutr, 1995;62S:1517S-20S.
48. Hankinson SE and Stampfer MJ: All that glitters is not beta carotene. JAMA, 1994;272:1455-6.